<DOC>
	<DOCNO>NCT03080012</DOCNO>
	<brief_summary>In tuberculosis patient , salivary concentration compare plasma/serum concentration several anti-tuberculosis drug . If salivary concentration correctly represent blood concentration , non-invasive sampling saliva could use TDM test drug .</brief_summary>
	<brief_title>Salivary Therapeutic Drug Monitoring Anti-Tuberculosis Drugs</brief_title>
	<detailed_description>TDM ( Therapeutic Drug Monitoring ) blood sample already part treatment tuberculosis ( TB ) patient reduce development drug resistance toxic drug concentration . Performing TDM saliva instead plasma serum could reduce burden blood sample . This study examine non-invasive sample saliva could use TDM several anti-TB drug . The study observational cohort study adult tuberculosis patient subject . The drug study isoniazid , rifampicin , ethambutol , pyrazinamide , moxifloxacin , amikacin , kanamycin , capreomycin , ethionamide , prothionamide , cycloserine , terizidone , linezolid , clofazimine , bedaquiline , delamanid , p-aminosalicylic acid ( PAS ) , imipenem-cilastatin , meropenem , ertapenem , amoxicillin-clavulanate thioacetazone . Saliva sample take simultaneously blood sample standard TDM . Serum/plasma saliva drug concentration determine validated LC-MS/MS ( liquid chromatography-tandem mass spectrometry ) method . The correlation linearity saliva plasma/serum concentration test . The saliva-plasma serum ratio base area time-concentration curve ( AUC ) calculate investigated anti-TB drug . Also pharmacokinetic parameter serum/plasma saliva calculate compare provide complete image pharmacokinetics anti-TB drug saliva .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Antitubercular Agents</mesh_term>
	<criteria>Tuberculosis confirm culture molecular test Patient treat antituberculosis drug include study Patient receive Therapeutic Drug Monitoring ( TDM ) routine care Patient sign informed consent Patient severe problem oral cavity , make saliva sample painful</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>